When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACRS - Aclaris up big on study of lead drug in COVID-19
Aclaris Therapeutics Inc.
Thinly traded nano cap Aclaris Therapeutics (NASDAQ:ACRS) rockets 83% premarket on robust volume in reaction to its announcement that the FDA has signed off an an investigator-initiated Phase 2a study evaluating lead candidate ATI-450 (on top of standard-of-care treatment) in 36 hospitalized COVID-19 patients with cytokine release syndrome (CRS), an acute systemic inflammatory response characterized by fever and multiple organ dysfunction.
More news on: Aclaris Therapeutics, Inc., Healthcare stocks news, Stocks on the move,